Altos Labs: Jeff Bezos Seeks to Defy Ageing, Death, Invests $3bn In New Science

Altos Labs: Jeff Bezos Seeks to Defy Ageing, Death, Invests $3bn In New Science

  • Seeking to defy age and death, the world’s wealthiest man, Jeff Bezos, has invested $3 billion into a new biotech company called Altos Labs
  • The company is focused on cellular rejuvenation programming to restore cell health and resilience, thereby reversing disease
  • The founder of Amazon also recently hired one of the world’s most respected scientists, Hal Barron

American entrepreneur and founder of Amazon, Jeff Bezos, has ventured into the science of anti-aging by investing in a biotech start-up, Altos Labs, which is focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine.

Jeffrey Preston Bezos is an American entrepreneur, media proprietor, investor, computer engineer, and commercial astronaut.

Looking into society’s desire for youthfulness, Bezos may just have stumbled upon his next million-dollar success project.

Read also

26 African YouTube Creators Selected to Join Second Year of #YouTubeBlack Voices Fund

Jeff Bezos, Ageing and Death, Altos Labs
Amazon founder Jeff Bezos invested $3 billion into a new biotech company called Altos Labs which seeks to take cellular reprogramming to another level. Image: Emma McIntyre/Getty Images
Source: Getty Images

It has been reported that Altos is pursuing biological reprogramming technology, a way to rejuvenate cells in the lab that some scientists think could be extended to revitalise entire animal bodies, ultimately prolonging human life.

PAY ATTENTION: Join Legit.ng Telegram channel! Never miss important updates!

According to Popular Mechanics, Bezos invested $3 billion in Altos Labs which has hit the ground running with what may be the single largest funding round for a biotech company, according to the Financial Times of London.

The American tycoon further recruited one of the world’s most respected scientists Hal Barron from GlaxoSmithKline to help lead the biotech company, News24 reported.

What is cellular programming

Nature.com describes it as the process of inducing a desired cell fate by converting somatic cells from one lineage to another without transitioning through an intermediate pluripotent or multipotent state, which has been described as 'direct reprogramming', also known as 'transdifferentiation'.

Read also

The travails of a trailblazer, Kaycee Madu by Dr. Charles Ihejirika

In addition to increasing the understanding of cell fate specification and plasticity, direct reprogramming holds promises for regenerative medicine.

I want what she’s eating: Nigerians in disbelief as they spot videos of young-looking 50-year-old woman online

Meanwhile, the videos of an unknown 50-year-old woman had got Nigerians gushing on social media.

The woman was dressed in a beautiful yellow outfit as she posed with her husband who was dressed in traditional wear.

The couple looked sweet and subtly played with each other as they look at the camera.

Source: Legit.ng

Tags:
Usa
Online view pixel